Back to news archive
News
2022-05-17
Gradientech presents QuickMIC® clinical study results
Based on more than 3,800 drug-bug combinations and a total of 473 common sepsis-causing bacterial strains, including 64 patient samples the QuickMIC® study result showed an overall Essential Agreement (EA) of 94,7 %, an overall Categorical Agreement (CA) of 94,7 % and an impressive reproducibility between the study sites of 99.1%. Average time to result for all drug-bug combinations was just below 3 hours and 20 minutes.